Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II Trial of Intermittent Therapy in Patients with Metastatic Renal Cell Carcinoma Treated with Front-line Ipilimumab and Nivolumab.
Ornstein MC, George L, Wei W, Diaz-Montero CM, Rayman P, Martin A, Basu A, Beckermann KE, Nizam A, Wee CE, Gilligan TD, Gupta S, Rini BI. Ornstein MC, et al. Among authors: wee ce. Clin Genitourin Cancer. 2024 Dec;22(6):102181. doi: 10.1016/j.clgc.2024.102181. Epub 2024 Jul 31. Clin Genitourin Cancer. 2024. PMID: 39208489 Free article. Clinical Trial.
Management of testicular germ cell tumors.
Wee CE, Gilligan TD. Wee CE, et al. Clin Adv Hematol Oncol. 2023 Apr;21(4):179-188. Clin Adv Hematol Oncol. 2023. PMID: 37039725 Review.
Risk of Thromboembolism in Patients Receiving Immunotherapy-Based Combinations as Front-Line Therapy for Metastatic Renal Cell Carcinoma.
Schuster J, Sheng IY, Reddy CA, Khorana AA, Nizam A, Gupta S, Gilligan T, Wee CE, Sussman TA, Bonham A, Maroli K, Martin A, Ornstein MC. Schuster J, et al. Among authors: wee ce. Clin Genitourin Cancer. 2024 Apr;22(2):92-97. doi: 10.1016/j.clgc.2023.09.005. Epub 2023 Oct 5. Clin Genitourin Cancer. 2024. PMID: 37932205
Safety and Efficacy Outcomes in Immune Checkpoint Inhibitor-Treated Patients With Metastatic Urothelial Carcinoma Requiring Treatment Interruption or Discontinuation Due to Immune-Related Adverse Events.
Nizam A, Rader RK, Tzeng A, Wei W, Sheng IY, Martin A, Wee CE, Gilligan TD, Gupta S, Ornstein MC. Nizam A, et al. Among authors: wee ce. Clin Genitourin Cancer. 2024 Apr;22(2):368-379. doi: 10.1016/j.clgc.2023.12.007. Epub 2023 Dec 15. Clin Genitourin Cancer. 2024. PMID: 38245437
Surveillance after pediatric thymoma resection.
Wee CE, Molina JR. Wee CE, et al. Mediastinum. 2019 May 30;3:19. doi: 10.21037/med.2019.04.08. eCollection 2019. Mediastinum. 2019. PMID: 35118247 Free PMC article. No abstract available.
25 results